Dechra Pharmaceuticals

Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.

All Articles

Veterinary drugs maker Dechra Pharmaceuticals has steeled itself for a possible no-deal Brexit by shifting ownership of UK marketing authorisations

September 2, 2019

Veterinary drugmaker Dechra Pharmaceuticals today credited "strong" trading for an 18 per cent rise in revenue in the six months to

January 14, 2019

Content tagged with "Dechra Pharmaceuticals"